<DOC>
	<DOCNO>NCT00114803</DOCNO>
	<brief_summary>The hypothesis underlie study nasally administer calcitonin stabilize improve bone mineral density young patient ulcerative colitis Crohn 's disease . Patients participate receive either calcitonin placebo bone mineral density measure start , nine month , 18 month study . Participants also receive age appropriate dos vitamin D calcium supplement . Other serological measure vitamin D status obtain every 3 month study .</brief_summary>
	<brief_title>Nasal Calcitonin Treatment Bone Mineral Loss Children Adolescents With Inflammatory Bowel Disease</brief_title>
	<detailed_description>This institutional , randomized , placebo-controlled , double-blind clinical trial compare efficacy intranasally administer calcitonin ( plus oral supplement age-appropriate dos calcium vitamin D ) placebo nasal spray ( plus oral supplement age-appropriate dos calcium vitamin D ) maintain improve bone mineral density . Study subject 8 22 year old patient diagnosis inflammatory bowel disease ( ulcerative colitis Crohn 's disease ) low bone mineral density define DXA z score low -1.0 SD . Study end-point 18 month continuous administration nasal calcitonin placebo supplement . Bone mineral density measure dual energy X-Ray absorptiometry ( DXA ) begin study , 9 18 month . The study subject evaluate clinically nutritionally begin study , well every 3 month duration study . Laboratory value relevant calcium homeostasis bone turnover obtain every 3 month .</detailed_description>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Salmon calcitonin</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
	<criteria>Low bone mineral density define Age 8 22 year Diagnosis Crohn 's disease ulcerative colitis Receiving calcitonin biphosphonates , androgens growth hormone Steroid induce fracture past Pregnant Diagnosis kidney failure , polycystic ovary syndrome , malignancy</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>bone mineral density</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>osteopenia</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
	<keyword>DXA</keyword>
</DOC>